This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet’s syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet’s Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behçet's Syndrome Overall Damage Index was 0 (range 0–4). Colchicine was inefcacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p=0.46) or the concomitant therapy (p=0.30 for cDMARDs, p=1.00 for glucocorticoids); cDMARDs and bDMARDs were inefcacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefcacy (p=0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively afects response to biologic therapies.

Gaggiano, C., Maselli, A., Sfikakis, P., Laskari, K., Ragab, G., Hegazy, M., Laymouna, A., Lopalco, G., Almaghlouth, I., Asfina, K., Alahmed, O., Giardini Mayrink, H., Parente De Brito Antonelli, I., Cattalini, M., Piga, M., Sota, J., Gentileschi, S., Maggio, M., Opris-Belinski, D., Hatemi, G., Insalaco, A., Olivieri, A., Tufan, A., Karadeniz, H., Kardaş, R., La Torre, F., Cardinale, F., Marino, A., Guerriero, S., Ruscitti, P., Tarsia, M., Vitale, A., Caggiano, V., Telesca, S., Iannone, F., Parretti, V., Frassi, M., Aragona, E., Ciccia, F., Wiesik-Szewczyk, E., Ionescu, R., Şahin, A., Akkoç, N., Hinojosa-Azaola, A., Tharwat, S., Hernández-Rodríguez, J., Espinosa, G., Conti, G., Del Giudice, E., Govoni, M., Emmi, G., Fabiani, C., Balistreri, A., Frediani, B., Rigante, D., Cantarini, L., Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry, <<INTERNAL AND EMERGENCY MEDICINE>>, 2023; 2023 (18(3)): 743-754. [doi:10.1007/s11739-023-03215-w] [https://hdl.handle.net/10807/232827]

Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry

Rigante, Donato;
2023

Abstract

This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet’s syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet’s Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behçet's Syndrome Overall Damage Index was 0 (range 0–4). Colchicine was inefcacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p=0.46) or the concomitant therapy (p=0.30 for cDMARDs, p=1.00 for glucocorticoids); cDMARDs and bDMARDs were inefcacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefcacy (p=0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively afects response to biologic therapies.
2023
Inglese
Gaggiano, C., Maselli, A., Sfikakis, P., Laskari, K., Ragab, G., Hegazy, M., Laymouna, A., Lopalco, G., Almaghlouth, I., Asfina, K., Alahmed, O., Giardini Mayrink, H., Parente De Brito Antonelli, I., Cattalini, M., Piga, M., Sota, J., Gentileschi, S., Maggio, M., Opris-Belinski, D., Hatemi, G., Insalaco, A., Olivieri, A., Tufan, A., Karadeniz, H., Kardaş, R., La Torre, F., Cardinale, F., Marino, A., Guerriero, S., Ruscitti, P., Tarsia, M., Vitale, A., Caggiano, V., Telesca, S., Iannone, F., Parretti, V., Frassi, M., Aragona, E., Ciccia, F., Wiesik-Szewczyk, E., Ionescu, R., Şahin, A., Akkoç, N., Hinojosa-Azaola, A., Tharwat, S., Hernández-Rodríguez, J., Espinosa, G., Conti, G., Del Giudice, E., Govoni, M., Emmi, G., Fabiani, C., Balistreri, A., Frediani, B., Rigante, D., Cantarini, L., Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry, <<INTERNAL AND EMERGENCY MEDICINE>>, 2023; 2023 (18(3)): 743-754. [doi:10.1007/s11739-023-03215-w] [https://hdl.handle.net/10807/232827]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/232827
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact